An Italian cost-effectiveness analysis of paclitaxel albumin (nab-paclitaxel) versus conventional paclitaxel for metastatic breast cancer patients: the COSTANza study

PURPOSE: Paclitaxel albumin (nab-paclitaxel) is a nanoparticle albumin-bound paclitaxel formulation aimed at increasing therapeutic index in metastatic breast cancer. When compared to conventional paclitaxel, nab-paclitaxel has a reported longer time to progression, higher response, lower incidence...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Lazzaro, Carlo, Bordonaro, Roberto, Cognetti, Francesco, Fabi, Alessandra, De Placido, Sabino, Arpino, Grazia, Marchetti, Paolo, Botticelli, Andrea, Pronzato, Paolo, Martelli, Elisa
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Dove Medical Press 2013
Konular:
Review
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC3629871/
https://ncbi.nlm.nih.gov/pubmed/23610525
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CEOR.S41850
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller